Re: A Second Publication Shortlists Resverlogix Clinical Candidate Apabetalone for its Potential COVID-19 Effectiveness Including Reducing Cytokine Storms

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

barsax

Rank: Vice President [?]

Points: 848 [?]

Votes: 11 Score: 3.9 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: A Second Publication Shortlists Resverlogix Clinical Candidate Apabetalone for its Potential COVID-19 Effectiveness Including Reducing Cytokine Storms

posted on Oct 26, 2020 10:32AM

If I were a potential BP partner with RVX, I would probably want to time any partnering announcement with a major conference event....let's say for example...the AHA. just a thought

6 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply